43rd SCI Process Development Symposium

Synopsis

Process Development is the application of chemistry to the scale up of new synthetic processes from the laboratory, through pilot plant to full scale commercial manufacture and into life cycle management. It is an extremely broad discipline, crossing the boundaries between synthetic organic chemistry, process technology and chemical engineering.
The area of Process Development continues to be a challenging and important area for the research into and application of modern synthetic organic chemistry, as well as enabling technologies.  

---

Attendees

The symposium aims to bring together a wide range of speakers from across the Pharmaceutical, Agrochemical and Fine Chemical industries, as well as from an academic background. This meeting brings together experts from across the entire spectrum of the discipline to present state of the art process development.

---

Programme

The programme will be confirmed in due course.

SCI’s Fine Chemicals Group are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with full inclusivity where attendees from all backgrounds are welcome. We are open to offering flexible presentation options.

---

Sponsorship and Exhibitor information

To be added to the list to receive further information and prices in Autumn 2026, please email conferences@soci.org.

---

Accessibility Grants

SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.

---

Venue and Contact

---

Booking Process/Deadlines

Booking terms and conditions

---

CPD Info

All delegates attending this meeting are able to claim CPD points.

---

Organising committee

Matt Burns, AstraZeneca
John Carey, Indivior
Harvey Dale, Syngenta
Hilmar Weinmann, Johnson & Johnson    
Max Espensen, SCI/Pharmaron
Richard Horan, SCI/GSK
Robert Walton, SCI/Asymchem

---